Cargando…
Osteonecrosis of the jaws in patients treated with bisphosphonates
The literature describes an increasing presence of bisphosphonate-induced osteonecrosis of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the maxillofacial region, after bisphosphonate therapy, in the absence of prior maxillary radiotherapy. The present literature...
Autores principales: | Ata-Ali, Fadi, Ata-Ali, Javier, Flichy-Fernández, Antonio J., Bagan, José V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908812/ https://www.ncbi.nlm.nih.gov/pubmed/24558527 http://dx.doi.org/10.4317/jced.50649 |
Ejemplares similares
-
Concept, diagnosis and classification of bisphosphonate-associated
osteonecrosis of the jaws. A review of the literature
por: Gavaldá, Carmen, et al.
Publicado: (2016) -
Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: Associated clinical characteristics
por: Bagan, Leticia, et al.
Publicado: (2017) -
Serum levels of RANKL and OPG, and the RANKL/OPG
ratio in bisphosphonate-related osteonecrosis of the jaw: Are they
useful biomarkers for the advanced stages of osteonecrosis?
por: Bagan, Leticia, et al.
Publicado: (2017) -
Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw
por: Vescovi, Paolo, et al.
Publicado: (2014) -
Bisphosphonate-Related Osteonecrosis of the Jaw: Specificities
por: Paulo, Siri, et al.
Publicado: (2014)